Table 1. Patient demographics, clinical parameters and study participation of subjects completing neurocognitive testing (NCT) procedures.

StudyParticipation	Clinical parameter	Acute HCV/HIV(aHCV)	HIV monoinfection(HIVmono)	Difference betweengroups, p-value*
Overall	Number, n	24	57
	Age (years), median [IQR]	41 [36], [44]	47 [39, 56]	0.003
	Male gender, n (%)	24 (100)	50 (89)	0.10
	Time-elapsed since HIV diagnosis (years), median [IQR]	6 [3], [12]	11 [5], [16]	0.02
	Current CD4+(cells/µL), median [IQR]	590 [458, 745]	505 [382, 783]	0.29
	Nadir CD4+(cells/µL), median [IQR]	200 [215, 395]	205 [88, 283]	0.01
	Receiving antiretroviral therapy, n (%)	17 (71)	54 (95)	0.006
	Current plasma HIV viral load below 50 c/mL, n (%)	16 (67)†	54 (95)	0.002
	HIV viral load of remaining subjects (c/mL), median [IQR]	5797 [1136, 11758]	14182 [1095, 15952]	0.18
	Time elapsed since negative HCV RNA test (weeks), median [IQR]	24 [20], [32]	–	–
	Current ALT (IU), median [IQR]	213 [78, 237]	–	–
	Peak ALT (IU), median [IQR]	237 [180, 820]	–	–
	HCV genotype 1, n (%)	21 (88)	–	–
	Most recent HCV RNA (c/mL), median [IQR]	986855 [56650, 4315528]	–	–

Table 1 legend: HCV = hepatitis C virus; RNA: ribonucleic acid; ALT  =  alanine aminotransferase; IU = international units;

^†1 subject had VL 87 copies/mL at time of assessment, repeat <50 copies/mL, *using Fisher’s exact test or t-test].